REVERSE FLUX FILTRATION - A NEW MODE OF THERAPY IMPROVING THE EFFICACY OF HEPARIN - INDUCED EXTRACORPOREAL LDL PRECIPITATION IN HYPERLIPIDEMIC HEMODIALYSIS-PATIENTS

被引:8
作者
BOSCH, T [1 ]
SAMTLEBEN, W [1 ]
THIERY, J [1 ]
GURLAND, HJ [1 ]
SEIDEL, D [1 ]
机构
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,INST CLIN CHEM,W-8000 MUNICH 70,GERMANY
关键词
LDL APHERESIS; HELP; HEMODIALYSIS; HYPERCHOLESTEROLEMIA THERAPY; CORONARY HEART DISEASE; REVERSE FLUX FILTRATION;
D O I
10.1177/039139889301600204
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
In the steady state after a run-in phase of 3 months, the acute effects of 3 modifications of weekly heparin-induced extracorporeal LDL precipitation (HELP) were studied in 5 ESRD and 2 non-uremic hypercholesterolemic coronary patients. In ESRD patients (n=29 sessions), HELP reduced LDL-cholesterol (LDL-C) (56 +/- 7%) and fibrinogen (FIB) (54 +/- 10%) by a similar percentage as compared to non-uremic controls (60 +/- 4% and 61 +/- 3%, resp.; n=5). In order to eliminate the need for extra HELP sessions in addition to the normal dialysis regimen, newly developed hardware was then used to perform combined synchronous HELP/HD (n=12). However, premature precipitate filter plugging probably due to hyperfibrinogenemia in ESRD patients, accentuated by ultrafiltration (UF), decreased the corresponding reductions to 26 +/- 9% (LDL-C) and 34 +/- 11% (FIB). Therefore, the procedure was modified by reversing the filtrate flux through the precipitate filter membrane after 900 ml of treated plasma (''reverse flux filtration'', RFF, n=ll). Thus, in RFF-HELP/HD the LDL/FIB/heparin coprecipitate was deposited on both filter membrane sides which caused a significant enhancement of the filter capacity and improved reductions to 46 +/- 14% for LDL-C and 51 +/- 15% for FIB. Elution of the precipitate from the precipitate filter after the sessions showed that RFF-HELP/HD had trapped 1733 +/- 238 mg LDL-C and 8108 +/- 1876 mg FIB in ESRD patients, while HELP eliminated 1890 +/- 333 mg LDL-C and only 3663 +/- 369 mg FIB in non-uremics. Filter precipitate recoveries (relative to the mass removed from the patient plasma pool) amounted to 97 +/- 18% for LDL-C and 158 +/- 67% for FIB in the ESRD group treated by RFF-HELP/HD vs. 70 and 76% in the non-uremic HELP group. Probably, passive transport of lipoproteins and FIB from the interstitium into the vascular space caused repletion of this compartment during HELP/HD where an UF induced solvent drag is effective. In summary, the new RFF-HELP/HD procedure effectively reduced LDL-C and FIB in ESRD patients who could not be adequately treated by the conventional HELP/HD system.
引用
收藏
页码:75 / 85
页数:11
相关论文
共 17 条
[1]   LIPID ABNORMALITIES IN RENAL-DISEASE [J].
APPEL, G ;
SCHAEFER, E ;
MADIAS, NE ;
MADAIO, MP ;
HARRINGTON, JT ;
LEVEY, AS ;
NARAYAN, G ;
MEYER, K .
KIDNEY INTERNATIONAL, 1991, 39 (01) :169-183
[2]  
ARMSTRONG VW, 1987, THESIS U GOTTINGEN
[3]  
BOSCH T, 1992, NIEREN HOCHDRUCK, V21, P89
[4]  
BOSCH T, 1991, Journal of the American Society of Nephrology, V2, P233
[5]  
CUXART M, 1989, MED CLIN-BARCELONA, V92, P769
[6]  
EISENHAUER T, 1991, T AM SOC ART INT ORG, V37, pM496
[7]  
EISENHAUER T, 1987, T ASAIO, V33, P395
[8]   PUTATIVE ATHEROGENIC FACTORS IN PATIENTS WITH CHRONIC-RENAL-FAILURE [J].
GREEN, D ;
STONE, NJ ;
KRUMLOVSKY, FA .
PROGRESS IN CARDIOVASCULAR DISEASES, 1983, 26 (02) :133-144
[9]   MANAGEMENT OF HYPERLIPIDEMIA OF KIDNEY-DISEASE [J].
GRUNDY, SM .
KIDNEY INTERNATIONAL, 1990, 37 (03) :847-853
[10]   ANALYSIS OF CARDIOVASCULAR RISK-FACTORS IN CHRONIC-HEMODIALYSIS PATIENTS WITH SPECIAL ATTENTION TO THE HYPERLIPOPROTEINEMIAS [J].
HAHN, R ;
OETTE, K ;
MONDORF, H ;
FINKE, K ;
SIEBERTH, HG .
ATHEROSCLEROSIS, 1983, 48 (03) :279-288